businesspress24.com - GENEWIZ, Inc. Launches Ion Proton(TM) Services as Ion AmpliSeq(TM) Exome Certified Service Provider
 

GENEWIZ, Inc. Launches Ion Proton(TM) Services as Ion AmpliSeq(TM) Exome Certified Service Provider

ID: 1270173

(firmenpresse) - SOUTH PLAINFIELD, NJ -- (Marketwired) -- 10/07/13 -- , leading global genomic service provider, has now become an Ion AmpliSeq™ Exome Certified Service Provider.

Administered by Life Technologies, "[the] Ion AmpliSeq™ Exome Certified Service Provider Program is a network of validated service providers that enables any researcher to get high quality exome sequence, using small amounts of input material and with rapid turnaround."

With the Ion Proton™, GENEWIZ can deliver exome sequencing and RNA-Seq projects rapidly and cost-effectively, without the requirement of multiplexing large numbers of samples per run.

"As a full-service next generation sequencing provider, offering services on the Ion Proton™ enables GENEWIZ to best optimize experiments based on our customers' project needs," stated Ginger Zhou, Head of NGS (U.S.), GENEWIZ, Inc. "As an Ion AmpliSeq™ Exome Certified Service Provider, we can deliver high-quality results in as few as 7 business days. In addition to rapid results, this certification endorses the consistent level of quality data and service customers can count on from GENEWIZ."

is a global contract research organization (CRO) specializing in genomic services, including DNA sequencing, gene synthesis, molecular biology, genomic, bioinformatics, and GxP/CLIA regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.

Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; and Tokyo, Japan.



GENEWIZ, Inc.

Global Headquarters
115 Corporate Boulevard
South Plainfield, NJ 07080
+1-908-222-0711






Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Pharma-Bio Industry to Invest $4.3 Billion in Capital/MRO Project Starts in Fourth-Quarter 2013, an Industrial Info News Alert
Threshold Pharmaceuticals Announces New Data on TH-302 to Be Presented at AACR-NCI-EORTC
Bereitgestellt von Benutzer: Marketwired
Datum: 07.10.2013 - 10:00 Uhr
Sprache: Deutsch
News-ID 1270173
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SOUTH PLAINFIELD, NJ


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 217 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"GENEWIZ, Inc. Launches Ion Proton(TM) Services as Ion AmpliSeq(TM) Exome Certified Service Provider
"
steht unter der journalistisch-redaktionellen Verantwortung von

GENEWIZ, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von GENEWIZ, Inc.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 97


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.